Target intelligence / Profile preview

Cell/tissue regeneration and replacement

Molecular classification
Other
01

Overview

"Cell/tissue regeneration and replacement" is an overarching therapeutic field rather than a specific molecular target. It encompasses a range of strategies aiming to repair, regenerate, or replace damaged or diseased human tissues and organs. These approaches typically utilize **stem cells** (such as mesenchymal stem cells, human pluripotent stem cells, or induced pluripotent stem cells), tissue engineering, gene therapies, and biomaterials to drive or support the body’s natural regenerative capacities. Clinical applications include treatment of **degenerative diseases, injuries, organ failure, orthopedic defects, wounds, and some cases of aging**. Despite rapid advancements, challenges include standardization of therapies, safety (including tumor risk), immune compatibility, and evidence of long-term efficacy[1][2][3][4]. Because "cell/tissue regeneration and replacement" does not refer to a specific molecule, receptor, or druggable protein, it is not appropriate to classify it as a single target for therapeutic intervention. Rather, it is a domain comprising many potential molecular and cellular targets that may be exploited to achieve regenerative effects.

Other names
Regenerative medicineTissue engineeringCell regeneration therapyTissue regenerationCell replacement therapy
02

Mechanism of action

Induction of stem cell differentiation; Immune modulation; Promotion of tissue repair by growth factors; Inhibition of inflammation; Replacement of damaged or diseased cells with functional cells

03

Biological functions

Tissue regenerationCell proliferationOrgan repairHealingAnti-inflammationDifferentiation
04

Disease associations

Orthopedic diseaseCardiovascular diseaseNeurodegenerative disorderOphthalmic diseaseOrgan failurePeriodontal diseaseAnti-agingCancer (in some settings)Other
05

Safety considerations

TumorigenesisImmune rejectionUncontrolled cell proliferationIncomplete tissue integrationInfection riskStandardization of cell source and potency
06

Biomarkers

Varies with application (often cell surface markers for stem/progenitor cells, differentiation markers, secreted growth factors)

Beyond the preview

Go deeper on Cell/tissue regeneration and replacement.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell/tissue regeneration and replacement.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call